The US Food and Drug Administration wants advisory committee input on a new “inter-pandemic” process for updating licensed prototype pandemic influenza vaccines that is designed to make better-matched shots available prior to a pandemic.
US FDA Proposes New ‘Inter-Pandemic’ Pathway For Updating Flu Vaccines
The threat of a highly pathogenic avian influenza pandemic spurred the FDA to have its vaccine advisory committee comment on a new process to update licensed prototype pandemic flu vaccines.
